Get started
Processa Pharmaceuticals, Inc.Processa Pharmaceuticals, Inc.Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals, Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonals
Full chart
Full chart

Compare with Processa Pharmaceuticals, Inc.



Key stats


Market capitalization
‪6.03 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−5.59 USD
Net income (FY)
‪−13.56 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪2.36 M‬
Beta (1Y)
0.64

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
12
Change (1Y)
+2+20.00%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.13 M‬ USD

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
George K. Ng
Website
processapharmaceuticals.com
Headquarters
Vero Beach
Founded
2011
IPO date
Oct 2, 2020
ISIN
US74275C4033
CUSIP
74275C403
FIGI
BBG003MN5ZP8
Identifiers
ISIN US74275C4033
CFI code
ESVUFR
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of PCSA is 1.99 USD — it has decreased by −4.63% in the past 24 hours. Watch Processa Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Processa Pharmaceuticals, Inc. stocks are traded under the ticker PCSA.
PCSA stock has risen by 0.49% compared to the previous week, the month change is a −21.07% fall, over the last year Processa Pharmaceuticals, Inc. has showed a −55.78% decrease.
PCSA reached its all-time high on Nov 22, 2013 with the price of 196,186.13 USD, and its all-time low was 1.67 USD and was reached on Jul 8, 2026. View more price dynamics on PCSA chart.
See other stocks reaching their highest and lowest prices.
PCSA stock is 9.09% volatile and has beta coefficient of 0.64. Track Processa Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Processa Pharmaceuticals, Inc. there?
Today Processa Pharmaceuticals, Inc. has the market capitalization of ‪6.03 M‬, it has decreased by −0.47% over the last week.
Yes, you can track Processa Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Processa Pharmaceuticals, Inc. is going to release the next earnings report on Oct 29, 2026. Keep track of upcoming events with our Earnings Calendar.
PCSA net income for the last quarter is ‪−3.27 M‬ USD, while the quarter before that showed ‪−3.38 M‬ USD of net income which accounts for 0.00% change. Track more Processa Pharmaceuticals, Inc. financial stats to get the full picture.
No, PCSA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 9, 2026, the company has 12 employees. See our rating of the largest employees — is Processa Pharmaceuticals, Inc. on this list?
Like other stocks, PCSA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Processa Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Processa Pharmaceuticals, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Processa Pharmaceuticals, Inc. stock shows the sell signal. See more of Processa Pharmaceuticals, Inc. technicals for a more comprehensive analysis.